# Humanitas Gavazzeni

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/humanitas-gavazzeni/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 44 |
| Citations | 75,322 |
| City | Bergamo |
| Country | IT |
| Description | Humanitas Gavazzeni is a research organisation in Bergamo, IT. OpenAlex records 1,781 works and 75,322 citations for it. 413 researchers list it as their most recent affiliation. |
| Homepage | http://www.gavazzeni.it/ |
| OpenAlex ID | https://openalex.org/I4210123782 |
| Researchers | 413 |
| ROR ID | https://ror.org/035jrer59 |
| Type | healthcare |
| Works | 1,781 |

## University papers

- [Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer](https://scholariq.org/papers/crizotinib-versus-chemotherapy-in-advanced-i-alk-i-positive-lung-cancer/)
- [Ceritinib in <i>ALK</i> -Rearranged Non–Small-Cell Lung Cancer](https://scholariq.org/papers/ceritinib-in-i-alk-i-rearranged-non-small-cell-lung-cancer/)
- [Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis](https://scholariq.org/papers/cancer-immunotherapy-efficacy-and-patients-sex-a-systematic-review-and-meta/)
- [Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/efficacy-of-the-mage-a3-cancer-immunotherapeutic-as-adjuvant-therapy-in-patients/)
- [Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial](https://scholariq.org/papers/activity-and-safety-of-ceritinib-in-patients-with-alk-rearranged-non-small-cell/)
- [A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)](https://scholariq.org/papers/a-randomized-phase-ii-study-of-the-mek1-mek2-inhibitor-trametinib-gsk1120212/)
- [Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis](https://scholariq.org/papers/sex-based-heterogeneity-in-response-to-lung-cancer-immunotherapy-a-systematic/)
- [Breast phyllodes tumor: A review of literature and a single center retrospective series analysis](https://scholariq.org/papers/breast-phyllodes-tumor-a-review-of-literature-and-a-single-center-retrospective/)
- [Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With <i>ALK</i> -Positive Non–Small-Cell Lung Cancer](https://scholariq.org/papers/pooled-analysis-of-cns-response-to-alectinib-in-two-studies-of-pretreated/)
- [Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy](https://scholariq.org/papers/phase-ii-study-of-everolimus-in-patients-with-thymoma-and-thymic-carcinoma/)
- [Correlation between treatments and outcomes of patients with EGFR-mutated non-small-cell lung cancer that transitioned into small-cell lung cancer: an international retrospective study](https://scholariq.org/papers/correlation-between-treatments-and-outcomes-of-patients-with-egfr-mutated-non/)

## University researchers

- [Tommaso De Pas](https://scholariq.org/researchers/tommaso-de-pas/)

## University top topics

Showing 8 of 25.

- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Pleural and Pulmonary Diseases](https://scholariq.org/topics/pleural-and-pulmonary-diseases/)
- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.